Related Experiment Videos
Long-term adherence to intensified conventional insulin therapy
K Schmidt1, B O Boehm, E Schifferdecker
1J. W. Goethe-University, School of Medicine, Department of Endocrinology, Frankfurt/Main.
Summary
Intensified conventional insulin therapy (ICT) significantly lowered blood glucose levels in diabetic patients long-term. Patients showed high compliance, demonstrating ICT
Area of Science:
- Endocrinology
- Metabolic Diseases
- Diabetes Management
Background:
- Intensified conventional insulin therapy (ICT) is a treatment approach for diabetes.
- Evaluating the long-term efficacy and safety of ICT in an outpatient setting is crucial.
Purpose of the Study:
- To retrospectively evaluate the long-term outcomes of intensified conventional insulin therapy (ICT) in diabetic patients.
- To assess patient compliance and the practicability of ICT under routine conditions.
Main Methods:
- Retrospective analysis of 141 diabetic patients initiating ICT between 1980 and 1991.
- Monitoring of glycosylated hemoglobin (HbA1) levels over a minimum of one year.
- Tracking changes in therapy, such as switching to continuous subcutaneous insulin infusion (CSII).
Main Results:
- Mean HbA1 levels significantly decreased from 9.3% to 8.5% within the first year and remained near normal.
- No association found between HbA1 levels and patient demographics or treatment adherence factors.
- Fourteen patients transitioned to CSII, with no permanent return to conventional therapy.
Conclusions:
- ICT provides a safe and practicable long-term solution for lowering blood glucose levels in diabetic patients.
- High patient compliance and sustained glycemic control were observed under routine outpatient conditions.
- ICT requires acceptable time commitment from patients and medical staff, without necessitating initial hospitalization.